{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:14:16Z","timestamp":1761110056672},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1016\/s0213-005x(02)72829-2","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T13:44:39Z","timestamp":1364996679000},"page":"407-412","source":"Crossref","is-referenced-by-count":9,"title":["Aspectos farmacocin\u00e9ticos y farmacodin\u00e1micos para la lectura interpretada del antibiograma"],"prefix":"10.1016","volume":"20","author":[{"given":"Francisco","family":"Soriano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0213-005X(02)72829-2_bib0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/jac\/30.5.567","article-title":"Optimal dosage of \u03b2lactam antibiotics: Time above the MIC and inoculum effect (leading article)","volume":"30","author":"Soriano","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0010","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1128\/AAC.40.12.2686","article-title":"Correlation of pharmacodynamic parameters of five \u03b2lactam antibiotics with therapeutic efficacy in an animal model","volume":"40","author":"Soriano","year":"1996","journal-title":"Antimicrobial Agents Chemother"},{"issue":"Suppl A","key":"10.1016\/S0213-005X(02)72829-2_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jac\/38.suppl_A.141","article-title":"Relevance of the Alexander Project: Pharmacodynamic considerations","volume":"38","author":"Drusano","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0020","first-page":"173","article-title":"Criterios de susceptibilidad antibacteriana in vitro","volume":"13","author":"Soriano","year":"1995","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe penumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallar\u00e9s","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0002-9343(88)90061-7","article-title":"Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci","volume":"84","author":"Viladrich","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1128\/AAC.40.1.218","article-title":"High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins","volume":"40","author":"Viladrich","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jac\/23.5.743","article-title":"Azithromycin (CP-62,993) in acute exacerbations of chronic bronchitis: An open clinical, microbiological and pharmacokinetic study","volume":"23","author":"Davies","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.44.1.43-50.2000","article-title":"Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children","volume":"44","author":"Dagan","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/45.suppl_2.9","article-title":"Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: Influence of pharmacokinetic and pharmacodynamic variables","volume":"45","author":"Tran","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0002-9343(84)80092-3","article-title":"Changing concepts and new applications of antibiotic pharmacokinetics","volume":"77","author":"Craig","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/Pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0065","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0025-7753(01)72202-6","article-title":"Selecci\u00f3n de bacterias resistentes a los antimicrobianos: factores microbiol\u00f3gicos y farmacol\u00f3gicos","volume":"117","author":"Soriano","year":"2001","journal-title":"Med Clin"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0028-1104083","article-title":"Dosis-Wirkungs-Beziehung der Bakterizidie bei E.coli, K.pneumoniae und Staphylococcus aureus","volume":"101","author":"Shah","year":"1976","journal-title":"Dtsch Med Wochenschr"},{"issue":"Suppl D","key":"10.1016\/S0213-005X(02)72829-2_bib0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/31.suppl_D.149","article-title":"Post-antibiotic effects in experimental infection models: Relationship to in vitro phenomena and to treatment of infections in man","volume":"31","author":"Craig","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0080","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jac\/27.6.829","article-title":"Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli","volume":"27","author":"Fantin","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: Importance of the ratio of peak concentration to minimal inhibitory concentration","volume":"155","author":"Moore","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0090","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","article-title":"Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients","volume":"37","author":"Forrest","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0095","first-page":"103","article-title":"Lectura farmacodin\u00e1mica de la susceptibilidad antibi\u00f3tica a Streptococcus pneumoniae","volume":"113","author":"Soriano","year":"1999","journal-title":"Med Clin"},{"issue":"Suppl 1","key":"10.1016\/S0213-005X(02)72829-2_bib0100","first-page":"44","article-title":"Dosificaci\u00f3n ideal y pauta de administraci\u00f3n de los antibi\u00f3ticos betalact\u00e1micos orales en el tratamiento de la infecci\u00f3n neumoc\u00f3cica","volume":"11","author":"Soriano","year":"1993","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0105","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.43.3.672","article-title":"Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection","volume":"43","author":"Lacy","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0732-8893(95)00053-D","article-title":"Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins","volume":"22","author":"Craig","year":"1995","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00006454-199603000-00015","article-title":"Pharmacokinetics and pharmacodynamics of antibiotics in otitis media","volume":"15","author":"Craig","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0120","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00006454-199312000-00001","article-title":"Microbiological efficacy of antibacterial drugs for acute otitis media","volume":"12","author":"Klein","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0125","first-page":"303","article-title":"Grupo MENSURA. Criterios del grupo MENSURA para la definici\u00f3n de los puntos cr\u00edticos de sensibilidad a los antibi\u00f3ticos","volume":"10","author":"Baquero","year":"1997","journal-title":"Rev Esp Quimiot"},{"issue":"Suppl D","key":"10.1016\/S0213-005X(02)72829-2_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/27.suppl_D.1-a","article-title":"Working Party of the British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing","volume":"27","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF01974543","article-title":"the Comit\u00e9 de l\u2019Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France","volume":"13","author":"Soussy","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0140","unstructured":"National Committee for Clinical Laboratory Standards. 2001.Performance standards for antimicrobial susceptibility testing; eleventh informational supplement. Vol 21, number 1, M100-S11. Wayne, Pennsylvania, USA"},{"issue":"Suppl","key":"10.1016\/S0213-005X(02)72829-2_bib0145","first-page":"5","article-title":"Antimicrobial susceptibility testing in Sweden. I. The work of the Swedish reference group for antibiotics (SRGA and SRGA-M)","volume":"105","author":"Olsson-Liljequist","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/S0213-005X(02)72829-2_bib0150","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/31.6.1001","article-title":"BSAC guidelines on sensitivity testing","volume":"31","author":"Williams","year":"1993","journal-title":"J Antimicrob Chemother"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X02728292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X02728292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T18:18:26Z","timestamp":1562869106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X02728292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0213005X02728292"],"URL":"https:\/\/doi.org\/10.1016\/s0213-005x(02)72829-2","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}